サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565600

人工網膜インプラントの世界市場：製品・用途・エンドユーザー・地域別の予測 (～2032年)

Global Artificial Retina Implant Market Research Report Information by Product, by Application, and by End User and by Region - Forecast till 2032

出版日
ページ情報
英文 77 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
人工網膜インプラントの世界市場：製品・用途・エンドユーザー・地域別の予測 (～2032年)
出版日: 2024年08月10日
発行: Market Research Future
ページ情報: 英文 77 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工網膜インプラントの市場規模は、2025年の15億1,000万米ドル、2026年の19億2,000万米ドルから、予測期間中は21.22%のCAGRで推移し、2032年には70億4,000万米ドルの規模に成長すると予測されています。

網膜色素変性症や加齢黄斑変性症 (AMD) の有病率の上昇、人工網膜インプラントを提供する新興企業の増加が、世界市場の拡大を後押しする主な理由です。

地域別展望

北米地域の2025年の市場シェアは50.12%超です。加齢黄斑変性 (AMD) の有病率の上昇とFDA認可のインプラント製品が利用可能であることから、北米の人工網膜インプラント市場が最大のシェアを示しています。

欧州市場は2025年から2026年にかけて大幅に拡大すると予想されています。これは主に、顧客の需要を満たすために参入企業が戦略的提携を頻繁に結んでいるためです。

アジア太平洋地域の人工網膜インプラント市場は、予測期間中にもっとも速い速度で発展すると予想されています。これは同地域の高齢者人口が増加しているためであり、業界の成長に大きく貢献する見通しです。Asia-Pacific Report on Population Ageing 2022によれば、2022年にはアジア太平洋地域の60歳以上の人口が6億7,000万人以上になると推計されています。アジア太平洋地域では、2050年までに人口が3倍の約13億人になると予測されています。

当レポートでは、世界の人工網膜インプラントの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 加齢黄斑変性症 (AMD) と網膜色素変性症の発生率増加
  • 抑制要因
    • 人工網膜インプラント手術に伴う高額な費用
  • 機会
    • 人工網膜インプラントへの資金と投資の増加

第5章 市場要因分析

  • ポーターのファイブフォース分析
  • 視力喪失を治療するための脳インプラントを開発する主要企業

第6章 世界の人工網膜インプラント市場：製品タイプ別

  • 概要
  • 網膜上インプラント
  • 網膜下インプラント
  • 脈絡膜上インプラント

第7章 世界の人工網膜インプラント市場：用途別

  • 概要
  • 加齢黄斑変性症 (AMD)
  • 網膜色素変性症

第8章 世界の人工網膜インプラント市場：地域別

  • 概要

第9章 競合情勢

  • 競合ダッシュボード
  • 公開企業の株式概要
  • 比較分析：主要企業の財務動向
  • 主な展開・成長戦略

第10章 企業プロファイル

  • VIVANI MEDICAL INC.
  • IBIONICS
  • NANOVISION BIOSCIENCES
  • SENSOR-TECH LAB
  • LABTICIAN OPHTHALMICS, INC
  • OPTOBIONICS
  • LAMBDAVISION, INC.
  • BIONIC VISION TECHNOLOGIES
  • PIXIUM VISION
  • AXORUS
  • DATA CITATIONS
図表

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
  • TABLE 3 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025-2032 (USD THOUSAND)
  • TABLE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, 2025-2032 (USD THOUSAND)
  • TABLE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025-2032 (USD THOUSAND)
  • TABLE 6 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 7 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 8 PARTNERSHIP
  • TABLE 9 EXPANSION
  • TABLE 10 MERGER
  • TABLE 11 VIVANI MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 12 VIVANI MEDICAL, INC.: KEY DEVELOPMENTS
  • TABLE 13 IBIONICS: PRODUCTS OFFERED
  • TABLE 14 NANOVISON: PRODUCTS OFFERED
  • TABLE 15 SENSOR-TECH LAB: PRODUCTS OFFERED
  • TABLE 16 LABTICIAN OPHTHALMICS, INC: PRODUCTS OFFERED
  • TABLE 17 OPTOBIONICS: PRODUCTS OFFERED
  • TABLE 18 LAMBDAVISION, INC.: PRODUCTS OFFERED
  • TABLE 19 BIONIC VISION TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 20 BIONIC VISION TECHNOLOGIES: KEY DEVELOPMENTS
  • TABLE 21 PIXIUM VISION: PRODUCTS OFFERED
  • TABLE 22 PIXIUM VISION: KEY DEVELOPMENTS
  • TABLE 23 AXORUS: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: STRUCTURE
  • FIGURE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ARTIFICIAL RETINA IMPLANT MARKET
  • FIGURE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025 & 2032 (USD THOUSAND)
  • FIGURE 6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY PRODUCT TYPE, 2025 (% SHARE)
  • FIGURE 7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 9 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 10 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY REGION, 2025 (% SHARE)
  • FIGURE 11 COMPETITOR DASHBOARD: ARTIFICIAL RETINA MARKET
  • FIGURE 12 VIVANI MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 13 VIVANI MEDICAL, INC.: SWOT ANALYSIS
  • FIGURE 14 IBIONICS: SWOT ANALYSIS
  • FIGURE 15 LABTICIAN OPHTHALMICS, INC: SWOT ANALYSIS
  • FIGURE 16 LAMBDAVISION, INC.: SWOT ANALYSIS
  • FIGURE 17 PIXIUM VISION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 PIXIUM VISION: SWOT ANALYSIS
目次
Product Code: MRFR/MED/2095-CR

Global Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Synopsis

The market for artificial retinal implants was estimated to be worth USD 1.51 billion in 2025. The Artificial Retina Implant market is expected to expand at a compound annual growth rate (CAGR) of 21.22% between 2026 and 2032, from USD 1.92 billion in 2026 to USD 7.04 billion.

The rising prevalence of retinitis pigmentosa and age-related macular degeneration (AMD), as well as the rise in the number of startups offering artificial retina implants, are the main reasons propelling the expansion of the global market.

In September 2021, Bionic Vision Technologies, a well-known brand in artificial retina technology, announced a significant collaboration with Cirtec Medical, a top medical technology business with its headquarters located in the US. The collaborative effort will facilitate the design process and allow for cooperative production of the next generation of bionic eyes. With the resources and expertise base of Cirtec Medical at its disposal, Bionic Vision Technologies hopes to advance its cutting-edge bionic eye technology and provide improved vision solutions for those with visual impairments.

Insights on Market Segments

The Artificial Retina Market is divided into three segments based on product type: suprachoroidal implants, subretinal implants, and epiretinal implants.

The artificial retina market has been divided into two segments based on application: retinitis pigmentosa and age-related macular degeneration (AMD).

Regional Perspectives

The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. With a market share of more than 50.12% in 2025, the artificial retina implant market in North America held the biggest share due to the rising prevalence of age-related macular degeneration (AMD) and the availability of FDA-approved implant products. For example, Argus II is a product that the FDA has approved and is accessible in the United States.

The artificial retina implant market in Europe is expected to increase significantly between 2025 and 2026, primarily due to the frequent strategic alliances formed by industry participants to meet customer demand. For example, Pixium Vision (France) revealed in July 2022 that the first patient in the Netherlands had a successful implantation in the Prima System European pivotal trial PRIMAvera. Since then, Pixium Vision has created more clinical locations and implanted patients in the UK and Germany.

The Asia-Pacific artificial retina implant market is expected to develop at the quickest rate during the forecast period due to the region's growing geriatric population, which is expected to significantly contribute to the industry's growth. For example, the Asia-Pacific Report on Population Ageing 2022 estimates that 670 million or more persons in Asia-Pacific were 60 years of age or older in 2022. In the Asia-Pacific region, the population is predicted to treble to almost 1.3 billion by 2050.

Key Players

Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc. (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), and Nanovision (US) are some of the prominent companies in the artificial retina implant market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE AND ASSUMPTIONS
  • 2.5 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF AGE-RELATED MACULAR DEGENERATION (AMD) AND RETINITIS PIGMENTOSA
    • 4.2.2 GROWING NUMBER OF STARTUPS ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT PROCEDURES
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING FUNDING & INVESTMENT FOR ARTIFICIAL RETINA IMPLANT

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 KEY PLAYERS DEVELOPING BRAIN IMPLANTS TO TREAT VISION LOSS

6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2. EPIRETINAL IMPLANTS
  • 6.3. SUBRETINAL IMPLANTS
  • 6.4. SUPRACHOROIDAL IMPLANTS

7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2. AGE-RELATED MACULAR DEGENERATION (AMD)
  • 7.3. RETINITIS PIGMENTOSA

8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION

  • 8.1 OVERVIEW

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 COMPETITOR DASHBOARD
  • 9.3 PUBLIC PLAYERS STOCK SUMMARY
  • 9.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.5.1 PARTNERSHIP
    • 9.5.2 EXPANSION
    • 9.5.3 MERGER

10 COMPANY PROFILES

  • 10.1 VIVANI MEDICAL INC.
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 IBIONICS
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGY
  • 10.3 NANOVISION BIOSCIENCES
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGY
  • 10.4 SENSOR-TECH LAB
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGY
  • 10.5 LABTICIAN OPHTHALMICS, INC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 OPTOBIONICS
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 LAMBDAVISION, INC.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 BIONIC VISION TECHNOLOGIES
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS/SERVICES OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 PIXIUM VISION
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 AXORUS
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 DATA CITATIONS